Showing results (241-250 of 586) with videos related to
Sort By:
Pageof 59
The American Journal of Cardiology|October 24, 2007
Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study)Michael D Ezekowitz, Paul A Reilly, Gerhard Nehmiz, et al.European Heart Journal|September 28, 2020
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillationLars Wallentin, Johan Lindbäck, Niclas Eriksson, et al.Journal of the American College of Cardiology|September 5, 2006
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkersCynthia M Westerhout, Yuling Fu, Michael S Lauer, et al.American Heart Journal|July 24, 2007
No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trialCynthia M Westerhout, Judy Gnarpe, Wei-Ching Chang, et al.European Heart Journal|May 12, 2009
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery diseaseChristoph Varenhorst, Stefan James, David Erlinge, et al.Circulation|December 29, 2012
Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trialAntonio L Dans, Stuart J Connolly, Lars Wallentin, et al.The American Journal of Cardiology|September 3, 2019
Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)Sarah A Goldstein, Jennifer Green, Kurt Huber, et al.JAMA Cardiology|November 15, 2018
Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker StudyDaniel Lindholm, Stefan K James, Katja Gabrysch, et al.European Heart Journal|September 10, 2013
Physical activity in patients with stable coronary heart disease: an international perspectiveRalph Stewart, Claes Held, Rebekkah Brown, et al.Circulation|December 11, 2013
Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysisZiad Hijazi, Stefan H Hohnloser, Jonas Oldgren, et al.Pageof 59